Harrell Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Sell
584
-93
-14% -$95K 0.15% 100
2026
Q1
$623K Buy
677
+25
+4% +$25.3K 0.15% 101
2025
Q4
$701K Buy
652
+65
+11% +$62.2K 0.17% 85
2025
Q3
$448K Sell
587
-2
-0.3% -$1.49K 0.11% 101
2025
Q2
$459K Sell
589
-129
-18% -$100K 0.12% 100
2025
Q1
$593K Buy
718
+184
+34% +$153K 0.18% 72
2024
Q4
$412K Buy
534
+60
+13% +$49.7K 0.12% 76
2024
Q3
$420K Sell
474
-3
-0.6% -$2.7K 0.12% 73
2024
Q2
$432K Buy
477
+16
+3% +$12.8K 0.13% 76
2024
Q1
$358K Buy
461
+7
+2% +$4.98K 0.11% 75
2023
Q4
$264K Hold
454
0.08% 88
2023
Q3
$244K Buy
454
+1
+0.2% +$515 0.08% 93
2023
Q2
$213K Buy
+453
New +$190K 0.07% 97

Other funds holding LLY

Harrell Investment Partners's LLY Position: Q2 2026 in Review

Harrell Investment Partners reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $95K and leaving 584 shares worth $701K. The position accounts for 0.15% of the portfolio, ranked #100.

Harrell Investment Partners first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 1,313 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Harrell Investment Partners held 584 shares of Eli Lilly worth $701K as of Q2 2026.
  • Harrell Investment Partners sold 93 Eli Lilly shares in Q2 2026, an estimated $95K.
  • Eli Lilly made up 0.15% of Harrell Investment Partners's portfolio in Q2 2026, its #100 holding.
  • Harrell Investment Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 1,313 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Harrell Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.